Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome. 1999

D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
Department of Internal Medicine, University of Palermo, Palermo, Italy.

BACKGROUND Lipoprotein(a) [Lp(a)] is a lipoprotein consisting of a low-density lipoprotein (LDL) particle linked to a polymorphic glycoprotein, apoprotein(a) [apo(a)]. Prior studies have reported high Lp(a) levels in the nephrotic syndrome, but it is still controversial whether this is due to the degree of hypoalbuminemia or proteinuria. METHODS To investigate a model of nephrotic syndrome in the absence of renal failure, we studied a group of 84 children in different clinical stages of the disease for a period of five years. We evaluated the direct relationships between lipoproteins, including Lp(a), and/or plasma albumin and proteinuria. RESULTS Lp(a) levels were significantly higher in the subjects with the active disease compared with patients in remission, and were also significantly different when subjects were ranked by albumin quartiles. Multiple regression analysis revealed that Lp(a) levels were inversely correlated with apo(a) isoform size and plasma albumin levels but not with the proteinuria/creatinine clearance ratio. Among subjects in complete remission, Lp(a) levels were different in patients with albumin levels below or above the fifth percentile. After the improvement of the clinical stage of the disease, the Delta% variation of albumin levels was related to the Delta% of apoB and LDL cholesterol (LDL-C), but not with the Delta% variation of Lp(a), whereas the Delta% variation of LDL-C was, in turn, related to the Delta% of Lp(a) levels. CONCLUSIONS These results suggest that in the childhood nephrotic syndrome, the increased Lp(a) levels are mainly related to hypoalbuminemia, probably through a mechanism involving apoB overproduction, which leads to an increased number of LDL particles to be converted into Lp(a).

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B

Related Publications

D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
January 1994, Annals of internal medicine,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
August 1992, Internal medicine (Tokyo, Japan),
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
January 1980, Pediatric research,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
December 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
June 1985, The New England journal of medicine,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
March 2001, Clinical nephrology,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
March 1967, American journal of diseases of children (1960),
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
January 2019, Frontiers in pediatrics,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
September 2012, Clinical nephrology,
D Noto, and C M Barbagallo, and A L Cascio, and A B Cefalù, and G Cavera, and R Caldarella, and G Marino, and S Travali, and I Cutaia, and S Maringhini, and A Notarbartolo, and M Averna
April 1990, East African medical journal,
Copied contents to your clipboard!